Cargando…
The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures
BACKGROUND: Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease characterized by episodes of acute subcutaneous swelling, and/or recurrent severe abdominal pain. The disease is potentially fatal if the upper-airway is involved. Iatrogenic harm can o...
Autores principales: | Valerieva, Anna, Cicardi, Marco, Baraniuk, James, Staevska, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201585/ https://www.ncbi.nlm.nih.gov/pubmed/30386388 http://dx.doi.org/10.1186/s13223-018-0275-4 |
Ejemplares similares
-
Therapeutic management of hereditary angioedema: past, present, and future
por: Valerieva, Anna, et al.
Publicado: (2021) -
Safety Aspects and Rational Use of Lanadelumab Injections in the Treatment of Hereditary Angioedema (HAE): Clinical Insights
por: Petkova, Elena, et al.
Publicado: (2022) -
Treatment of hereditary angioedema—single or multiple pathways to the rescue
por: Valerieva, Anna, et al.
Publicado: (2022) -
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry()
por: Valerieva, Anna, et al.
Publicado: (2021) -
Ongoing Contact Activation in Patients with Hereditary Angioedema
por: Konings, Joke, et al.
Publicado: (2013)